Evidence-based guide to co-occurring schizophrenia and addiction — prevalence, the relationship between psychosis and substance use, and integrated treatment approaches.
Schizophrenia and addiction are among the most challenging co-occurring conditions in psychiatry. People with schizophrenia have dramatically elevated rates of substance use disorder — particularly tobacco, cannabis, and alcohol — and co-occurring addiction significantly worsens schizophrenia outcomes. The relationship between schizophrenia and addiction is complex, involving shared neurobiological mechanisms, self-medication, and the social circumstances of people with severe mental illness. Understanding this relationship is essential for effective treatment of both conditions.
Schizophrenia: A severe mental illness characterized by positive symptoms (hallucinations, delusions, disorganized thinking), negative symptoms (flat affect, avolition, alogia), and cognitive impairment.
Positive symptoms: Symptoms that represent an excess or distortion of normal function — hallucinations, delusions, disorganized speech and behavior.
Negative symptoms: Symptoms that represent a diminution of normal function — flat affect, avolition (lack of motivation), alogia (poverty of speech), anhedonia.
Antipsychotic medications: Medications used to treat schizophrenia that block dopamine D2 receptors. First-generation (typical) and second-generation (atypical) antipsychotics.
Dual diagnosis: The co-occurrence of a substance use disorder and a mental health disorder.
The co-occurrence of schizophrenia and addiction is extremely common:
Self-medication: People with schizophrenia may use substances to manage symptoms — cannabis and alcohol for their anxiolytic effects, stimulants for their mood-elevating effects, nicotine for its cognitive-enhancing effects.
Shared neurobiological vulnerability: Schizophrenia and addiction share neurobiological risk factors — including dopamine system dysregulation and prefrontal cortex hypofunction. This shared vulnerability may explain the high co-occurrence of the two conditions.
Social circumstances: People with schizophrenia often live in poverty, have limited social connections, and are exposed to substance-using environments — all of which increase addiction risk.
Cannabis and psychosis: Cannabis use is a significant risk factor for psychosis and schizophrenia, particularly in people with genetic vulnerability. High-potency cannabis (high THC) is associated with a 5-fold elevated risk of psychosis. Cannabis use in people with established schizophrenia worsens psychotic symptoms and increases relapse risk.
Co-occurring schizophrenia and addiction presents significant treatment challenges:
Medication adherence: People with schizophrenia and addiction often have poor medication adherence — both due to the cognitive effects of substances and due to the disorganization of schizophrenia.
Engagement in treatment: People with schizophrenia and addiction are often difficult to engage in treatment — due to cognitive impairment, paranoia, and the social circumstances of severe mental illness.
Diagnostic complexity: Substance use can mimic or mask schizophrenia symptoms, making accurate diagnosis difficult. Substance-induced psychosis must be distinguished from schizophrenia.
Integrated treatment — addressing both schizophrenia and addiction simultaneously — is more effective than sequential treatment:
Antipsychotic medications: Clozapine — the most effective antipsychotic for treatment-resistant schizophrenia — has also shown evidence of reducing substance use in people with co-occurring schizophrenia and addiction. Long-acting injectable antipsychotics improve medication adherence.
Motivational interviewing: MI is particularly effective for engaging people with schizophrenia and addiction in treatment, given their often ambivalent motivation for change.
Assertive Community Treatment (ACT): An intensive, team-based community treatment model that provides comprehensive services — including medication management, case management, and substance use treatment — to people with severe mental illness and addiction.
Supported employment and housing: Addressing the social circumstances of severe mental illness — through supported employment and stable housing — is an important component of integrated treatment.
Can cannabis cause schizophrenia?
Cannabis use is a significant risk factor for psychosis and schizophrenia, particularly in people with genetic vulnerability. However, cannabis does not cause schizophrenia in everyone who uses it — genetic vulnerability is an important moderating factor. High-potency cannabis (high THC) carries the greatest risk.
Can people with schizophrenia recover from addiction?
Yes. Recovery from addiction is possible for people with schizophrenia, though it typically requires more intensive and longer-term treatment than for people without schizophrenia. Integrated treatment that addresses both conditions simultaneously produces the best outcomes.
Related articles on Sobriety Navigator: Bipolar Disorder and Addiction, Addiction and Depression, Medication-Assisted Treatment, Trauma-Informed Care in Addiction Treatment.
Put this into practice with Recovery Compass
Track your sobriety, log daily check-ins, journal your journey, and celebrate every milestone — all private, all on your device.